For: | Gonçalves LL, Farias AQ, Gonçalves PL, D’Amico EA, Carrilho FJ. Branch retinal vein thrombosis and visual loss probably associated with pegylated interferon therapy of chronic hepatitis C. World J Gastroenterol 2006; 12(28): 4602-4603 [PMID: 16874884 DOI: 10.3748/wjg.v12.i28.4602] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v12/i28/4602.htm |
Number | Citing Articles |
1 |
Adil Jaulim, Badia Ahmed, Tina Khanam, Irini P. Chatziralli. BRANCH RETINAL VEIN OCCLUSION. Retina 2013; 33(5): 901 doi: 10.1097/IAE.0b013e3182870c15
|
2 |
Clara M Castillejo Becerra, Yue Ding, Beatrice Kenol, Andrew Hendershot, Alexa Simon Meara. Ocular side effects of antirheumatic medications: a qualitative review. BMJ Open Ophthalmology 2020; 5(1): e000331 doi: 10.1136/bmjophth-2019-000331
|
3 |
A. Such Díaz, N. Barrueco, C. Esteban Alba, I. Escobar Rodríguez. Trombosis venosa retiniana asociada a peginterferón alfa 2b más ribavirina en un paciente con hepatitis C crónica. Farmacia Hospitalaria 2011; 35(2): 93 doi: 10.1016/j.farma.2010.01.010
|
4 |
Wenlan Zhang, Paul Hahn. Handbook of Venous Thromboembolism. 2017; : 216 doi: 10.1002/9781119095606.ch24
|
5 |
|
6 |
Mehrdad Afarid, Hamid Lashkarizadeh, MohammadJ Ashraf, MohammadHossein Nowroozzadeh, SayedM Shafiee. The efficacy of intravitreal interferon alpha-2b for the treatment of experimental endotoxin-induced uveitis. Indian Journal of Ophthalmology 2016; 64(5): 376 doi: 10.4103/0301-4738.185605
|
7 |
A. Viennet, F. Glatre, F. Bacin. Rétinopathie à interferon alpha 2b et ribavirine chez un patient atteint d’une hépatite C chronique. Journal Français d'Ophtalmologie 2009; 32(7): 505 doi: 10.1016/j.jfo.2009.04.007
|
8 |
J.J. Napal Lecumberri, C. Sedano Balbas, J. Cañal Villanueva, J.L. Hernández Hernández. Thrombophilia and vascular risk factors in retinal vein occlusion. Revista Clínica Española (English Edition) 2013; 213(5): 229 doi: 10.1016/j.rceng.2013.05.002
|
9 |
I. Sanlés González, J.J. Napal Lecumberri, R. Pérez-Montes, A. Cerveró Varona, A. Casado Rojo, J.L. Hernández Hernández. Oclusión venosa retiniana en pacientes menores de 50 años. Análisis de factores de riesgo vascular, trombofilia, hallazgos ecográficos carotídeos y etiologías poco frecuentes. Archivos de la Sociedad Española de Oftalmología 2022; 97(8): 443 doi: 10.1016/j.oftal.2021.12.003
|
10 |
Matthew Driban, Nikita Kedia, Supriya Arora, Jay Chhablani. Novel pharmaceuticals for the management of retinal vein occlusion and linked disorders. Expert Review of Clinical Pharmacology 2023; 16(11): 1125 doi: 10.1080/17512433.2023.2277882
|
11 |
Ligita Jancoriene, Dovile Norvydaite, Saulius Galgauskas, Evelina Balciunaite. Transient Visual Loss in a Hepatitis C Patient Treated With Pegylated Interferon Alfa-2a and Ribavirin. Hepatitis Monthly 2014; 14(2) doi: 10.5812/hepatmon.15124
|
12 |
Yong Dae Kwon, Ji Won Lim. Clinical Features of Retinopathy in Chronic Hepatitis B Patients With Treated With Peginterferon. Journal of the Korean Ophthalmological Society 2011; 52(1): 41 doi: 10.3341/jkos.2011.52.1.41
|
13 |
Michael R Narkewicz, Philip Rosenthal, Kathleen B Schwarz, Arlene Drack, Todd Margolis, Michael X Repka. Ophthalmologic Complications in Children With Chronic Hepatitis C Treated With Pegylated Interferon. Journal of Pediatric Gastroenterology and Nutrition 2010; 51(2): 183 doi: 10.1097/MPG.0b013e3181b99cf0
|
14 |
Joon Hyung Yeo, Kyoung Woo Kim, Jae Chan Kim. Mooren’s ulcerative keratitis after systemic pegylated interferon alpha2a in chronic hepatitis C. Canadian Journal of Ophthalmology 2017; 52(5): e163 doi: 10.1016/j.jcjo.2017.03.018
|
15 |
Chia-Hsiang Shih, Shu-Yu Ou, Chia-Jen Shih, Yung-Tai Chen, Shuo-Ming Ou, Yi-Jung Lee. Bidirectional association between the risk of comorbidities and the diagnosis of retinal vein occlusion in an elderly population: A nationwide population-based study. International Journal of Cardiology 2015; 178: 256 doi: 10.1016/j.ijcard.2014.10.110
|
16 |
Sohan Singh Hayreh. Ocular Vascular Occlusive Disorders. 2015; : 771 doi: 10.1007/978-3-319-12781-1_26
|
17 |
Hassan Seddik, Mouna Tamzaourte, Fadoua Rouibaa, Maha Fadlouallah, Ahmed Benkirane. Irreversible Anterior Ischemic Optic Neuropathy Complicating Interferon Alpha and Ribaverin Therapy. International Journal of Hepatology 2011; 2011: 1 doi: 10.4061/2011/814242
|
18 |
L. De Simone, P. Gentile, R. Aldigeri, V. Mastrofilippo, E. Bolletta, F. Gozzi, C. Adani, C. Salvarani, L. Cimino. Effectiveness of Pegylated Interferon Alpha-2a in Post-Uveitic Macular Edema Previously Responding to Non-Pegylated Interferon. Ocular Immunology and Inflammation 2024; 32(5): 678 doi: 10.1080/09273948.2023.2195494
|
19 |
Javier S. Martinez de Aragon, Jose S. Pulido, Christopher L. Haupert, Christopher F. Blodi, Jared S. Nielsen, Lee M. Jampol. INTERFERON-β–ASSOCIATED RETINOPATHY. RETINAL Cases & Brief Reports 2009; 3(1): 24 doi: 10.1097/ICB.0b013e31814b160d
|
20 |
Hee Young Kang, Min Chul Shin. Pegylated Interferon-Associated Severe Retinopathy in a Patient with Chronic Hepatitis. Korean Journal of Ophthalmology 2012; 26(2): 147 doi: 10.3341/kjo.2012.26.2.147
|
21 |
N. Kabbaj, S. Sentissi, M. Mohammadi, A. Benaïssa, N. Amrani. Anterior ischemic optic neuropathy complicating interferon alpha and ribavirin therapy in patients with chronic hepatitisC. Gastroentérologie Clinique et Biologique 2009; 33(2): 115 doi: 10.1016/j.gcb.2008.12.004
|
22 |
Supriya Arora, Thamolwan Surakiatchanukul, Tarun Arora, Marie Helene Errera, Hitesh Agrawal, Marco Lupidi, Jay Chhablani. Retinal toxicities of systemic anticancer drugs. Survey of Ophthalmology 2022; 67(1): 97 doi: 10.1016/j.survophthal.2021.05.007
|
23 |
Yi-Hsuan Wei, I-Hua Wang, Lin-Chung Woung, Jieh-Ren Jou. Anterior Ischemic Optic Neuropathy Associated with Pegylated Interferon Therapy for Chronic Hepatitis C. Ocular Immunology and Inflammation 2009; 17(3): 191 doi: 10.1080/09273940802687820
|
24 |
Masaaki Watanabe, Sumie Ogasawara, Akihiko Takahashi, Juichi Takada, Yoshiaki Tanaka, Yusuke Okuwaki, Tsutomu Minamino, Hisashi Hidaka, Takahide Nakazawa, Akitaka Shibuya, Wasaburo Koizumi. Branch retinal artery occlusion and central retinal vein occlusion associated with pegylated interferon plus ribavirin combination therapy for chronic hepatitis C. Cutaneous and Ocular Toxicology 2012; 31(3): 253 doi: 10.3109/15569527.2011.641197
|
25 |
J.J. Napal Lecumberri, C. Sedano Balbas, J. Cañal Villanueva, J.L. Hernández Hernández. Trombofilia y factores de riesgo vascular en la obstrucción venosa retiniana. Revista Clínica Española 2013; 213(5): 229 doi: 10.1016/j.rce.2013.01.012
|
26 |
I. Sanlés González, J.J. Napal Lecumberri, R. Pérez-Montes, A. Cerveró Varona, A. Casado Rojo, J.L. Hernández Hernández. Retinal vein occlusion in patients under 50 years. Analysis of vascular risk factors, thrombophilia, carotid ultrasound findings and uncommon aetiologies. Archivos de la Sociedad Española de Oftalmología (English Edition) 2022; 97(8): 443 doi: 10.1016/j.oftale.2021.12.002
|
27 |
Hillary C. Stiefel, Laura J. Kopplin, Thomas Albini, Michael Chang, Sravanthi Vegunta, Eric B. Suhler. Treatment of Refractory Cystoid Macular Edema with Pegylated Interferon Alfa-2A: A Retrospective Chart Review. Ocular Immunology and Inflammation 2021; 29(3): 566 doi: 10.1080/09273948.2019.1687729
|
28 |
O. Leaman-Alcibar, F. López-Campos, J. Aller, Ana Calín-Lorca, E. Zatarain-Nicolás, M. F. Bande, A. Navarro-Martin. Handbook of Cancer and Immunology. 2023; : 1 doi: 10.1007/978-3-030-80962-1_339-1
|